Insider Transactions Reported by 5 Insiders of Theriva Biologics, Inc.

Symbol
TOVX on NYSE
Location
Rockville, MD

There are no Buy or Sell transactions made by insiders since 13 Mar 2025

Theriva Biologics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John J. Monahan Director 05 Jan 2026
Steven A. Shallcross CEO and CFO, Director 05 Jan 2026
Jeffrey Alan Wolf Director 05 Jan 2026
Jeffrey J. Kraws Director 05 Jan 2026
Francis Tufaro Chief Operating Officer 15 Dec 2022

Recent Insider Transactions by Companies or Individuals for Theriva Biologics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Steven A. Shallcross TOVX Stock Options (right to buy) Award 475,000 475,000 05 Jan 2026 Direct
John J. Monahan TOVX Stock Options (right to buy) Award 75,000 75,000 05 Jan 2026 Direct
Jeffrey J. Kraws TOVX Stock Options (right to buy) Award 75,000 75,000 05 Jan 2026 Direct
Jeffrey Alan Wolf TOVX Stock Options (right to buy) Award 75,000 75,000 05 Jan 2026 Direct
Jeffrey Alan Wolf TOVX Stock Options (right to buy) Award 25,000 25,000 29 Apr 2025 Direct
Steven A. Shallcross TOVX Stock Options (right to buy) Award 190,000 190,000 29 Apr 2025 Direct
John J. Monahan TOVX Stock Options (right to buy) Award 25,000 25,000 29 Apr 2025 Direct
Jeffrey J. Kraws TOVX Stock Options (right to buy) Award 25,000 25,000 29 Apr 2025 Direct
Steven A. Shallcross TOVX Stock Options (right to buy) Award 700,000 700,000 14 Dec 2023 Direct
Jeffrey Alan Wolf TOVX Stock Options (right to buy) Award 110,000 110,000 14 Dec 2023 Direct
Jeffrey J. Kraws TOVX Stock Options (right to buy) Award 110,000 110,000 14 Dec 2023 Direct
John J. Monahan TOVX Stock Options (right to buy) Award 110,000 110,000 14 Dec 2023 Direct
Steven A. Shallcross TOVX Common Stock Purchase 5.93% $9,703 $0.6931 14,000 250,000 07 Jun 2023 Direct
Steven A. Shallcross TOVX Common Stock Purchase 12.4% $16,453 $0.6328 26,000 236,000 06 Jun 2023 Direct
Steven A. Shallcross TOVX Common Stock Purchase 13.5% $26,075 $1.04 25,000 210,000 10 Feb 2023 Direct
Steven A. Shallcross TOVX Common Stock Purchase 15.6% $23,512 $0.9405 25,000 185,000 02 Feb 2023 Direct
Steven A. Shallcross TOVX Common Stock Purchase 18.5% $21,825 $0.8730 25,000 160,000 25 Jan 2023 Direct
Steven A. Shallcross TOVX Common Stock Purchase 22.7% $18,705 $0.7482 25,000 135,000 20 Jan 2023 Direct
Steven A. Shallcross TOVX Common Stock Purchase 1000% $43,700 $0.4370 100,000 110,000 29 Dec 2022 Direct
Francis Tufaro TOVX Stock Options (right to buy) Award 100,000 100,000 15 Dec 2022 Direct
Jeffrey Alan Wolf TOVX Stock Options (right to buy) Award 100,000 100,000 15 Dec 2022 Direct
Jeffrey J. Kraws TOVX Stock Options (right to buy) Award 100,000 100,000 15 Dec 2022 Direct
Steven A. Shallcross TOVX Stock Options (right to buy) Award 475,000 475,000 15 Dec 2022 Direct
John J. Monahan TOVX Stock Options (right to buy) Award 100,000 100,000 15 Dec 2022 Direct
Jeffrey Alan Wolf TOVX Stock Options (right to buy) Award 200,000 200,000 23 Dec 2021 Direct
Jeffrey J. Kraws TOVX Stock Options (right to buy) Award 200,000 200,000 23 Dec 2021 Direct
Steven A. Shallcross TOVX Stock Options (right to buy) Award 650,000 650,000 23 Dec 2021 Direct
John J. Monahan TOVX Stock Options (right to buy) Award 200,000 200,000 23 Dec 2021 Direct
Steven A. Shallcross TOVX Common Stock Purchase 100% $24,595 $0.4919 50,000 100,000 10 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.